Search Browse Earnings

Forte Biosciences, Inc. — SlamSEC

Forte Biosciences, Inc.

Nasdaq:FBRX

Pharmaceutical Preparations·DALLAS, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$41,000

-16.3% YoY

FY 2019

Adj. EBITDA

-$32.5M

-79212.2% margin

FY 2024

Net Income

-$31.5M

-76770.7% margin

FY 2024

EPS (Diluted)

-$24.92

FY 2024

Stock Price

$27.38

-3.2%

2026-03-11

52W Range

$4.90 – $35.62

P/E Ratio

-1.1x

Market Cap

$343.0M

Cash

$37.1M

FY 2024

Total Debt

$30.9M

FY 2019

Net Cash

$6.2M

FY 2019

Enterprise Value

$336.8M

Debt / EBITDA

0.2x

FY 2019

EV / EBITDA

-10.4x

Employees

—